$LSCC
Lattice Semiconductor Corp

2013 Q2 Form 10-Q Financial Statement

#000085565813000106 Filed on August 06, 2013

View on sec.gov

Income Statement

Concept 2013 Q2 2012 Q2
Revenue $84.69M $70.79M
YoY Change 19.64% -14.31%
Cost Of Revenue $39.58M $33.74M
YoY Change 17.32% 2.23%
Gross Profit $45.11M $37.05M
YoY Change 21.75% -25.31%
Gross Profit Margin 53.26% 52.34%
Selling, General & Admin $17.07M $19.41M
YoY Change -12.02% 13.02%
% of Gross Profit 37.85% 52.37%
Research & Development $20.27M $19.36M
YoY Change 4.67% -3.86%
% of Gross Profit 44.93% 52.26%
Depreciation & Amortization $4.900M $5.300M
YoY Change -7.55% 29.81%
% of Gross Profit 10.86% 14.3%
Operating Expenses $37.34M $38.77M
YoY Change -3.69% 3.91%
Operating Profit $7.015M -$2.786M
YoY Change -351.79% -126.62%
Interest Expense $700.0K
YoY Change 0.0%
% of Operating Profit
Other Income/Expense, Net -$54.00K $694.0K
YoY Change -107.78% 4.68%
Pretax Income $6.961M -$2.092M
YoY Change -432.74% -118.8%
Income Tax $1.921M $10.45M
% Of Pretax Income 27.6%
Net Earnings $5.040M -$12.54M
YoY Change -140.18% -214.86%
Net Earnings / Revenue 5.95% -17.72%
Basic Earnings Per Share $0.04 -$0.11
Diluted Earnings Per Share $0.04 -$0.11
COMMON SHARES
Basic Shares Outstanding 115.7M shares 117.9M shares
Diluted Shares Outstanding 117.1M shares 117.9M shares

Balance Sheet

Concept 2013 Q2 2012 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $174.2M $184.5M
YoY Change -5.58% -21.72%
Cash & Equivalents $99.28M $132.5M
Short-Term Investments $74.90M $52.00M
Other Short-Term Assets $13.30M $16.00M
YoY Change -16.88% 88.24%
Inventory $49.65M $37.12M
Prepaid Expenses
Receivables $63.61M $60.38M
Other Receivables $0.00 $0.00
Total Short-Term Assets $300.8M $298.0M
YoY Change 0.95% -10.27%
LONG-TERM ASSETS
Property, Plant & Equipment $41.73M $42.06M
YoY Change -0.79% 4.12%
Goodwill $44.81M $44.81M
YoY Change 0.0%
Intangibles $13.96M $16.90M
YoY Change -17.43%
Long-Term Investments $4.700M $4.700M
YoY Change 0.0% -36.49%
Other Assets $8.503M $8.510M
YoY Change -0.08% 240.4%
Total Long-Term Assets $127.5M $146.0M
YoY Change -12.71% 189.75%
TOTAL ASSETS
Total Short-Term Assets $300.8M $298.0M
Total Long-Term Assets $127.5M $146.0M
Total Assets $428.3M $444.0M
YoY Change -3.54% 16.08%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $32.80M $31.70M
YoY Change 3.47% 20.53%
Accrued Expenses $9.200M $7.200M
YoY Change 27.78% -13.25%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $55.90M $51.32M
YoY Change 8.93% 1.62%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00
YoY Change
Other Long-Term Liabilities $5.222M $20.50M
YoY Change -74.52% 425.56%
Total Long-Term Liabilities $5.222M $20.50M
YoY Change -74.52% 425.56%
TOTAL LIABILITIES
Total Short-Term Liabilities $55.90M $51.32M
Total Long-Term Liabilities $5.222M $20.50M
Total Liabilities $61.13M $71.82M
YoY Change -14.89% 32.26%
SHAREHOLDERS EQUITY
Retained Earnings -$257.6M -$255.2M
YoY Change 0.95%
Common Stock $624.2M $626.4M
YoY Change -0.34%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $367.2M $372.2M
YoY Change
Total Liabilities & Shareholders Equity $428.3M $444.0M
YoY Change -3.54% 16.08%

Cashflow Statement

Concept 2013 Q2 2012 Q2
OPERATING ACTIVITIES
Net Income $5.040M -$12.54M
YoY Change -140.18% -214.86%
Depreciation, Depletion And Amortization $4.900M $5.300M
YoY Change -7.55% 29.81%
Cash From Operating Activities -$3.200M -$3.000M
YoY Change 6.67% -190.23%
INVESTING ACTIVITIES
Capital Expenditures -$3.700M -$5.900M
YoY Change -37.29% -245.14%
Acquisitions
YoY Change
Other Investing Activities $1.500M $10.30M
YoY Change -85.44% -25.9%
Cash From Investing Activities -$2.400M $4.400M
YoY Change -154.55% -41.78%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -300.0K -5.500M
YoY Change -94.55% 95.24%
NET CHANGE
Cash From Operating Activities -3.200M -3.000M
Cash From Investing Activities -2.400M 4.400M
Cash From Financing Activities -300.0K -5.500M
Net Change In Cash -5.900M -4.100M
YoY Change 43.9% -150.83%
FREE CASH FLOW
Cash From Operating Activities -$3.200M -$3.000M
Capital Expenditures -$3.700M -$5.900M
Free Cash Flow $500.0K $2.900M
YoY Change -82.76% -491.89%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2012Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
36391000 USD
CY2013Q2 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
32819000 USD
CY2012Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
46947000 USD
CY2013Q2 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
63605000 USD
CY2013Q2 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-621000 USD
CY2012Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-261000 USD
CY2013Q2 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
624222000 USD
CY2012Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
621170000 USD
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
4423000 USD
CY2013Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
2511000 USD
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
3678000 USD
CY2012Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
2054000 USD
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
4423000 USD
CY2013Q2 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
1200000 USD
CY2013Q1 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
1100000 USD
CY2012Q4 us-gaap Assets
Assets
414619000 USD
CY2013Q2 us-gaap Assets
Assets
428300000 USD
CY2013Q2 us-gaap Assets Current
AssetsCurrent
300825000 USD
CY2012Q4 us-gaap Assets Current
AssetsCurrent
287069000 USD
CY2012Q4 us-gaap Available For Sale Securities
AvailableForSaleSecurities
69582000 USD
CY2013Q2 us-gaap Available For Sale Securities
AvailableForSaleSecurities
79665000 USD
CY2013Q2 us-gaap Available For Sale Securities Current
AvailableForSaleSecuritiesCurrent
74948000 USD
CY2012Q4 us-gaap Available For Sale Securities Current
AvailableForSaleSecuritiesCurrent
64865000 USD
CY2012Q4 us-gaap Available For Sale Securities Debt Maturities After Ten Years Fair Value
AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue
4717000 USD
CY2013Q2 us-gaap Available For Sale Securities Debt Maturities After Ten Years Fair Value
AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue
4717000 USD
CY2013Q2 us-gaap Available For Sale Securities Noncurrent
AvailableForSaleSecuritiesNoncurrent
4717000 USD
CY2012Q4 us-gaap Available For Sale Securities Noncurrent
AvailableForSaleSecuritiesNoncurrent
4717000 USD
CY2012Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
118536000 USD
CY2013Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
99276000 USD
CY2011Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
141423000 USD
CY2012Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
132468000 USD
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-19260000 USD
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-8955000 USD
CY2012Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2013Q2 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2012Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2013Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2012Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
300000000 shares
CY2013Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
300000000 shares
CY2012Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
115500000 shares
CY2013Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
115835579 shares
CY2012Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
115500000 shares
CY2013Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
115835579 shares
CY2013Q2 us-gaap Common Stock Value Outstanding
CommonStockValueOutstanding
1158000 USD
CY2012Q4 us-gaap Common Stock Value Outstanding
CommonStockValueOutstanding
1155000 USD
CY2012Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-12473000 USD
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-20097000 USD
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
6570000 USD
CY2013Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
4920000 USD
us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Concentration Risk</font></div><div style="line-height:120%;text-indent:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-indent:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Potential exposure to concentration risk consists primarily of cash and cash equivalents, marketable securities, trade receivables and supply of wafers for our new products. We place our investments primarily through three financial institutions and mitigate the concentration of credit risk by limiting the maximum portion of the investment portfolio which may be invested in any one instrument. The Company's investment policy defines approved credit ratings for investment securities. Investments on-hand consisted primarily of money market instruments, &#8220;AA&#8221; or better corporate notes and bonds, and U.S. government agency obligations. See Note 4 for a discussion of the liquidity attributes of our marketable securities.</font></div><div style="line-height:120%;text-align:left;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">&#160;</font></div><div style="line-height:120%;text-indent:30px;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">&#160;</font></div><div style="line-height:120%;text-indent:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> Concentration of credit risk with respect to trade receivables is mitigated by a geographically diverse customer base and our credit and collection process. Accounts receivable do not bear interest, and are shown net of allowances for doubtful accounts of </font><font style="font-family:Times New Roman;font-size:10pt;color:#000000;font-style:normal;font-weight:normal;text-decoration:none;">$1.2 million</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:Times New Roman;font-size:10pt;color:#000000;font-style:normal;font-weight:normal;text-decoration:none;">$1.1 million</font><font style="font-family:inherit;font-size:10pt;"> at </font><font style="font-family:Times New Roman;font-size:10pt;color:#000000;font-style:normal;font-weight:normal;text-decoration:none;">June 29, 2013</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:Times New Roman;font-size:10pt;color:#000000;font-style:normal;font-weight:normal;text-decoration:none;">December 29, 2012</font><font style="font-family:inherit;font-size:10pt;">, respectively. We perform credit evaluations for essentially all customers and secure transactions with letters of credit or advance payments where appropriate. We regularly review our allowance for doubtful accounts and the aging of our accounts receivable. Write-offs for uncollected trade receivables have not been significant to date. </font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-indent:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">We rely on a limited number of foundries for our wafer purchases including: Fujitsu Limited, Seiko Epson Corporation Taiwan Semiconductor Manufacturing Company, Ltd, United Microelectronics Corporation, and GLOBALFOUNDRIES.</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></div>
CY2013Q2 us-gaap Deferred Tax Assets Net Noncurrent
DeferredTaxAssetsNetNoncurrent
13757000 USD
CY2012Q4 us-gaap Deferred Tax Assets Net Noncurrent
DeferredTaxAssetsNetNoncurrent
15357000 USD
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
9962000 USD
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
10271000 USD
CY2012Q2 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
33741000 USD
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
65956000 USD
CY2013Q2 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
39584000 USD
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
72587000 USD
CY2012Q2 us-gaap Costs And Expenses
CostsAndExpenses
73578000 USD
us-gaap Costs And Expenses
CostsAndExpenses
145125000 USD
CY2013Q2 us-gaap Costs And Expenses
CostsAndExpenses
77679000 USD
us-gaap Costs And Expenses
CostsAndExpenses
146196000 USD
CY2013Q2 us-gaap Deferred Revenue And Credits Current
DeferredRevenueAndCreditsCurrent
13890000 USD
CY2012Q4 us-gaap Deferred Revenue And Credits Current
DeferredRevenueAndCreditsCurrent
10553000 USD
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.17
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.06
CY2013Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.04
CY2012Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
6149000 USD
CY2012Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.11
CY2013Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.04
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.17
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.06
CY2012Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.11
us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents
EffectOfExchangeRateOnCashAndCashEquivalents
-430000 USD
us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents
EffectOfExchangeRateOnCashAndCashEquivalents
261000 USD
CY2013Q2 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
9194000 USD
CY2013Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
2900000 USD
CY2013Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Year Three
FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
2900000 USD
CY2013Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
2900000 USD
us-gaap Fiscal Period
FiscalPeriod
<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-indent:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">We report based on a </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">52</font><font style="font-family:inherit;font-size:10pt;"> or </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">53</font><font style="font-family:inherit;font-size:10pt;">-week fiscal year ending on the Saturday closest to </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">December&#160;31</font><font style="font-family:inherit;font-size:10pt;">. Our </font><font style="font-family:Times New Roman;font-size:10pt;color:#000000;font-style:normal;font-weight:normal;text-decoration:none;">second</font><font style="font-family:inherit;font-size:10pt;"> quarter of fiscal </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">2013</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">second</font><font style="font-family:inherit;font-size:10pt;"> quarter of fiscal </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">2012</font><font style="font-family:inherit;font-size:10pt;"> ended on </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">June 29, 2013</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">June 30, 2012</font><font style="font-family:inherit;font-size:10pt;">, respectively. All references to quarterly, </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">three</font><font style="font-family:inherit;font-size:10pt;"> or </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">six</font><font style="font-family:inherit;font-size:10pt;"> months ended financial results are references to the results for the relevant fiscal period.</font></div></div>
us-gaap Gain Loss On Sale Of Securities Net
GainLossOnSaleOfSecuritiesNet
393000 USD
us-gaap Gain Loss On Sale Of Securities Net
GainLossOnSaleOfSecuritiesNet
0 USD
CY2013Q2 us-gaap Goodwill
Goodwill
44808000 USD
CY2012Q4 us-gaap Goodwill
Goodwill
44808000 USD
us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-1875000 USD
CY2013Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
6961000 USD
CY2012Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-2092000 USD
us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
9550000 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
18381000 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
2620000 USD
CY2012Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
10450000 USD
CY2013Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
1921000 USD
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
382000 USD
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
956000 USD
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-50000 USD
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-4726000 USD
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
16658000 USD
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
23387000 USD
us-gaap Increase Decrease In Deferred Income Taxes
IncreaseDecreaseInDeferredIncomeTaxes
-2108000 USD
us-gaap Increase Decrease In Deferred Income Taxes
IncreaseDecreaseInDeferredIncomeTaxes
-17750000 USD
us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
3337000 USD
us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
1595000 USD
us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
3045000 USD
us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
-2129000 USD
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-162000 USD
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
5460000 USD
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
374000 USD
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
2054000 USD
CY2013Q2 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
13957000 USD
CY2012Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
15430000 USD
CY2012Q4 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
16279000 USD
CY2013Q2 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
20776000 USD
CY2013Q2 us-gaap Inventory Net
InventoryNet
49654000 USD
CY2012Q4 us-gaap Inventory Net
InventoryNet
44194000 USD
CY2013Q2 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
28878000 USD
CY2012Q4 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
27915000 USD
CY2012Q4 us-gaap Liabilities
Liabilities
57069000 USD
CY2013Q2 us-gaap Liabilities
Liabilities
61125000 USD
us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
-22000 USD
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
259000 USD
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-4943000 USD
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-1368000 USD
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
8860000 USD
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-18369000 USD
us-gaap Net Income Loss
NetIncomeLoss
-20256000 USD
us-gaap Net Income Loss
NetIncomeLoss
6930000 USD
CY2012Q2 us-gaap Net Income Loss
NetIncomeLoss
-12542000 USD
CY2012Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
414619000 USD
CY2013Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
428300000 USD
CY2012Q4 us-gaap Liabilities Current
LiabilitiesCurrent
53093000 USD
CY2013Q2 us-gaap Liabilities Current
LiabilitiesCurrent
55903000 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-13133000 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
907000 USD
CY2013Q2 us-gaap Net Income Loss
NetIncomeLoss
5040000 USD
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-430000 USD
CY2012Q2 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
104000 USD
CY2012Q4 us-gaap Notional Amount Of Foreign Currency Derivatives
NotionalAmountOfForeignCurrencyDerivatives
150000000 JPY
CY2013Q2 us-gaap Notional Amount Of Foreign Currency Derivatives
NotionalAmountOfForeignCurrencyDerivatives
100000000 JPY
us-gaap Number Of Reportable Segments
NumberOfReportableSegments
1 segment
us-gaap Operating Income Loss
OperatingIncomeLoss
9656000 USD
CY2012Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-2786000 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
-2633000 USD
CY2013Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
7015000 USD
CY2012Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
6854000 USD
CY2013Q2 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
8503000 USD
us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
70000 USD
CY2013Q2 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-265000 USD
us-gaap Other Comprehensive Income Loss Reclassification Adjustment For Sale Of Securities Included In Net Income Net Of Tax
OtherComprehensiveIncomeLossReclassificationAdjustmentForSaleOfSecuritiesIncludedInNetIncomeNetOfTax
-78000 USD
CY2013Q2 us-gaap Other Comprehensive Income Loss Reclassification Adjustment For Sale Of Securities Included In Net Income Net Of Tax
OtherComprehensiveIncomeLossReclassificationAdjustmentForSaleOfSecuritiesIncludedInNetIncomeNetOfTax
229000 USD
CY2012Q2 us-gaap Other Comprehensive Income Loss Reclassification Adjustment For Sale Of Securities Included In Net Income Net Of Tax
OtherComprehensiveIncomeLossReclassificationAdjustmentForSaleOfSecuritiesIncludedInNetIncomeNetOfTax
-78000 USD
us-gaap Other Comprehensive Income Loss Reclassification Adjustment For Sale Of Securities Included In Net Income Net Of Tax
OtherComprehensiveIncomeLossReclassificationAdjustmentForSaleOfSecuritiesIncludedInNetIncomeNetOfTax
302000 USD
us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-232000 USD
CY2012Q2 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
43000 USD
us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-22000 USD
CY2013Q2 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-84000 USD
CY2013Q2 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
13342000 USD
CY2012Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
12527000 USD
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
1515000 USD
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
2668000 USD
CY2013Q2 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2012Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2013Q2 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2012Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2013Q2 us-gaap Preferred Stock Value
PreferredStockValue
0 USD
CY2012Q4 us-gaap Preferred Stock Value
PreferredStockValue
0 USD
CY2013Q2 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
5222000 USD
CY2012Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
3976000 USD
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-106000 USD
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
758000 USD
CY2013Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-54000 USD
CY2012Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
694000 USD
us-gaap Payments For Proceeds From Other Investing Activities
PaymentsForProceedsFromOtherInvestingActivities
1519000 USD
us-gaap Payments For Proceeds From Other Investing Activities
PaymentsForProceedsFromOtherInvestingActivities
2340000 USD
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
2452000 USD
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
6970000 USD
us-gaap Payments To Acquire Available For Sale Securities
PaymentsToAcquireAvailableForSaleSecurities
46209000 USD
us-gaap Payments To Acquire Available For Sale Securities
PaymentsToAcquireAvailableForSaleSecurities
16034000 USD
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
6837000 USD
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
8075000 USD
CY2013Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2012Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2013Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000 shares
CY2012Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000 shares
us-gaap Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities
ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities
36196000 USD
us-gaap Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities
ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities
35309000 USD
CY2013Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
41733000 USD
CY2012Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
40384000 USD
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
38381000 USD
CY2013Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
20267000 USD
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
38509000 USD
CY2012Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
19363000 USD
us-gaap Restructuring And Related Cost Incurred Cost
RestructuringAndRelatedCostIncurredCost
643000 USD
us-gaap Restructuring And Related Cost Incurred Cost
RestructuringAndRelatedCostIncurredCost
172000 USD
CY2012Q2 us-gaap Restructuring And Related Cost Incurred Cost
RestructuringAndRelatedCostIncurredCost
87000 USD
CY2013Q2 us-gaap Restructuring And Related Cost Incurred Cost
RestructuringAndRelatedCostIncurredCost
19000 USD
us-gaap Restructuring Charges
RestructuringCharges
761000 USD
us-gaap Restructuring Charges
RestructuringCharges
437000 USD
CY2012Q4 us-gaap Restructuring Reserve
RestructuringReserve
3424000 USD
CY2013Q2 us-gaap Restructuring Reserve
RestructuringReserve
710000 USD
CY2011Q4 us-gaap Restructuring Reserve
RestructuringReserve
1569000 USD
CY2012Q2 us-gaap Restructuring Reserve
RestructuringReserve
0 USD
us-gaap Restructuring Reserve Accrual Adjustment
RestructuringReserveAccrualAdjustment
-118000 USD
us-gaap Restructuring Reserve Accrual Adjustment
RestructuringReserveAccrualAdjustment
-265000 USD
us-gaap Restructuring Reserve Settled With Cash
RestructuringReserveSettledWithCash
2212000 USD
us-gaap Restructuring Reserve Settled With Cash
RestructuringReserveSettledWithCash
2886000 USD
CY2012Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-264514000 USD
CY2013Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-257584000 USD
us-gaap Revenues
Revenues
142492000 USD
CY2013Q2 us-gaap Revenues
Revenues
84694000 USD
CY2012Q2 us-gaap Revenues
Revenues
70792000 USD
us-gaap Revenues
Revenues
155852000 USD
us-gaap Sales Revenue Net
SalesRevenueNet
142492000 USD
CY2012Q2 us-gaap Sales Revenue Net
SalesRevenueNet
70792000 USD
CY2013Q2 us-gaap Sales Revenue Net
SalesRevenueNet
84694000 USD
us-gaap Sales Revenue Net
SalesRevenueNet
155852000 USD
CY2012Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
117874000 shares
CY2013Q2 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
17072000 USD
CY2012Q2 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
19405000 USD
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
37328000 USD
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
33570000 USD
us-gaap Share Based Compensation
ShareBasedCompensation
3678000 USD
us-gaap Share Based Compensation
ShareBasedCompensation
4423000 USD
us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
1084000 USD
us-gaap Stock Repurchased During Period Value
StockRepurchasedDuringPeriodValue
2452000 USD
CY2013Q2 us-gaap Stockholders Equity
StockholdersEquity
367175000 USD
CY2012Q4 us-gaap Stockholders Equity
StockholdersEquity
357550000 USD
us-gaap Treasury Stock Retired Cost Method Amount
TreasuryStockRetiredCostMethodAmount
0 USD
us-gaap Use Of Estimates
UseOfEstimates
<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Use of Estimates</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-indent:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The preparation of financial statements in conformity with U.S. generally accepted accounting principles requires management to make estimates and assumptions that affect the reported amounts and classification of assets, such as marketable securities, accounts receivable, net, inventory, auction rate securities, goodwill - including the assessment of reporting unit, intangible assets, current and deferred income taxes, accrued liabilities - including restructuring charges and bonus arrangements, deferred income and allowances on sales to sell-through distributors, disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenue and expenses during the fiscal periods presented. Actual results could differ from those estimates.</font></div></div>
us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
0 shares
CY2012Q2 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
0 shares
us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
1373000 shares
CY2013Q2 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
1376000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
116935000 shares
CY2013Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
117109000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
118024000 shares
CY2012Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
117874000 shares
CY2013Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
115733000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
115562000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
118024000 shares
CY2012Q4 lscc Available For Sale Securities Debt Maturities Of Less Than Five Years Fair Value
AvailableForSaleSecuritiesDebtMaturitiesOfLessThanFiveYearsFairValue
64865000 USD
CY2013Q2 lscc Available For Sale Securities Debt Maturities Of Less Than Five Years Fair Value
AvailableForSaleSecuritiesDebtMaturitiesOfLessThanFiveYearsFairValue
74948000 USD
lscc Business Acquisition Acquisition Related Costs
BusinessAcquisitionAcquisitionRelatedCosts
1486000 USD
CY2012Q2 lscc Business Acquisition Acquisition Related Costs
BusinessAcquisitionAcquisitionRelatedCosts
982000 USD
lscc Business Acquisition Acquisition Related Costs
BusinessAcquisitionAcquisitionRelatedCosts
2689000 USD
CY2013Q2 lscc Business Acquisition Acquisition Related Costs
BusinessAcquisitionAcquisitionRelatedCosts
737000 USD
CY2012Q4 lscc Deferred Income And Allowances On Sales To Sell Through Distributors Allowance For Distributor Advances
DeferredIncomeAndAllowancesOnSalesToSellThroughDistributorsAllowanceForDistributorAdvances
22450000 USD
CY2013Q2 lscc Deferred Income And Allowances On Sales To Sell Through Distributors Allowance For Distributor Advances
DeferredIncomeAndAllowancesOnSalesToSellThroughDistributorsAllowanceForDistributorAdvances
23890000 USD
CY2012Q4 lscc Deferred Income And Allowances On Sales To Sell Through Distributors Deferred Cost Of Sales On Inventory Held By Sell Through Distributors
DeferredIncomeAndAllowancesOnSalesToSellThroughDistributorsDeferredCostOfSalesOnInventoryHeldBySellThroughDistributors
5620000 USD
CY2013Q2 lscc Deferred Income And Allowances On Sales To Sell Through Distributors Deferred Cost Of Sales On Inventory Held By Sell Through Distributors
DeferredIncomeAndAllowancesOnSalesToSellThroughDistributorsDeferredCostOfSalesOnInventoryHeldBySellThroughDistributors
5791000 USD
CY2012Q4 lscc Deferred Income And Allowances On Sales To Sell Through Distributors Inventory Valued At Published List Price And Held By Sell Through Distributors With Right Of Return
DeferredIncomeAndAllowancesOnSalesToSellThroughDistributorsInventoryValuedAtPublishedListPriceAndHeldBySellThroughDistributorsWithRightOfReturn
38623000 USD
CY2013Q2 lscc Deferred Income And Allowances On Sales To Sell Through Distributors Inventory Valued At Published List Price And Held By Sell Through Distributors With Right Of Return
DeferredIncomeAndAllowancesOnSalesToSellThroughDistributorsInventoryValuedAtPublishedListPriceAndHeldBySellThroughDistributorsWithRightOfReturn
43571000 USD
lscc Distribution Of Deferred Compensation From Trust Assets
DistributionOfDeferredCompensationFromTrustAssets
35000 USD
lscc Distribution Of Deferred Compensation From Trust Assets
DistributionOfDeferredCompensationFromTrustAssets
131000 USD
CY2012Q2 lscc Entity Wide Revenue By Geographic Area Percentage
EntityWideRevenueByGeographicAreaPercentage
1.00
lscc Entity Wide Revenue By Geographic Area Percentage
EntityWideRevenueByGeographicAreaPercentage
1.00
CY2013Q2 lscc Entity Wide Revenue By Geographic Area Percentage
EntityWideRevenueByGeographicAreaPercentage
1.00
lscc Entity Wide Revenue By Geographic Area Percentage
EntityWideRevenueByGeographicAreaPercentage
1.00
lscc Intercompany Sale Of Inventory And Fixed Assets Tax Expense Benefit
IntercompanySaleOfInventoryAndFixedAssetsTaxExpenseBenefit
18400000 USD
CY2012Q2 lscc Intercompany Sale Of Inventory And Fixed Assets Tax Expense Benefit
IntercompanySaleOfInventoryAndFixedAssetsTaxExpenseBenefit
10500000 USD
lscc Net Share Settlement Upon Issuance Of Restricted Stock Units
NetShareSettlementUponIssuanceOfRestrictedStockUnits
641000 USD
lscc Net Share Settlement Upon Issuance Of Restricted Stock Units
NetShareSettlementUponIssuanceOfRestrictedStockUnits
431000 USD
dei Amendment Flag
AmendmentFlag
false
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-28
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q2
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2013
dei Document Period End Date
DocumentPeriodEndDate
2013-06-29
dei Document Type
DocumentType
10-Q
dei Entity Central Index Key
EntityCentralIndexKey
0000855658
CY2013Q3 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
116097047 shares
dei Entity Filer Category
EntityFilerCategory
Accelerated Filer
dei Entity Registrant Name
EntityRegistrantName
LATTICE SEMICONDUCTOR CORP

Files In Submission

Name View Source Status
0000855658-13-000106-index-headers.html Edgar Link pending
0000855658-13-000106-index.html Edgar Link pending
0000855658-13-000106.txt Edgar Link pending
0000855658-13-000106-xbrl.zip Edgar Link pending
a2013q210q.htm Edgar Link pending
ex-3112013q210q.htm Edgar Link pending
ex-3122013q210q.htm Edgar Link pending
ex-3212013q210q.htm Edgar Link pending
ex-3222013q210q.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xls Edgar Link pending
lscc-20130629.xml Edgar Link completed
lscc-20130629.xsd Edgar Link pending
lscc-20130629_cal.xml Edgar Link unprocessable
lscc-20130629_def.xml Edgar Link unprocessable
lscc-20130629_lab.xml Edgar Link unprocessable
lscc-20130629_pre.xml Edgar Link unprocessable
R1.htm Edgar Link pending
R1.xml Edgar Link unprocessable
R10.htm Edgar Link pending
R10.xml Edgar Link unprocessable
R11.htm Edgar Link pending
R11.xml Edgar Link unprocessable
R12.htm Edgar Link pending
R12.xml Edgar Link unprocessable
R13.htm Edgar Link pending
R13.xml Edgar Link unprocessable
R14.htm Edgar Link pending
R14.xml Edgar Link unprocessable
R15.htm Edgar Link pending
R15.xml Edgar Link unprocessable
R16.htm Edgar Link pending
R16.xml Edgar Link unprocessable
R17.htm Edgar Link pending
R17.xml Edgar Link unprocessable
R18.htm Edgar Link pending
R18.xml Edgar Link unprocessable
R19.htm Edgar Link pending
R19.xml Edgar Link unprocessable
R2.htm Edgar Link pending
R2.xml Edgar Link unprocessable
R20.htm Edgar Link pending
R20.xml Edgar Link unprocessable
R21.htm Edgar Link pending
R21.xml Edgar Link unprocessable
R22.htm Edgar Link pending
R22.xml Edgar Link unprocessable
R23.htm Edgar Link pending
R23.xml Edgar Link unprocessable
R24.htm Edgar Link pending
R24.xml Edgar Link unprocessable
R25.htm Edgar Link pending
R25.xml Edgar Link unprocessable
R26.htm Edgar Link pending
R26.xml Edgar Link unprocessable
R27.htm Edgar Link pending
R27.xml Edgar Link unprocessable
R28.htm Edgar Link pending
R28.xml Edgar Link unprocessable
R29.htm Edgar Link pending
R29.xml Edgar Link unprocessable
R3.htm Edgar Link pending
R3.xml Edgar Link unprocessable
R30.htm Edgar Link pending
R30.xml Edgar Link unprocessable
R31.htm Edgar Link pending
R31.xml Edgar Link unprocessable
R32.htm Edgar Link pending
R32.xml Edgar Link unprocessable
R33.htm Edgar Link pending
R33.xml Edgar Link unprocessable
R34.htm Edgar Link pending
R34.xml Edgar Link unprocessable
R35.htm Edgar Link pending
R35.xml Edgar Link unprocessable
R36.htm Edgar Link pending
R36.xml Edgar Link unprocessable
R37.htm Edgar Link pending
R37.xml Edgar Link unprocessable
R38.htm Edgar Link pending
R38.xml Edgar Link unprocessable
R39.htm Edgar Link pending
R39.xml Edgar Link unprocessable
R4.htm Edgar Link pending
R4.xml Edgar Link unprocessable
R40.htm Edgar Link pending
R40.xml Edgar Link unprocessable
R41.htm Edgar Link pending
R41.xml Edgar Link unprocessable
R42.htm Edgar Link pending
R42.xml Edgar Link unprocessable
R43.htm Edgar Link pending
R43.xml Edgar Link unprocessable
R44.htm Edgar Link pending
R44.xml Edgar Link unprocessable
R5.htm Edgar Link pending
R5.xml Edgar Link unprocessable
R6.htm Edgar Link pending
R6.xml Edgar Link unprocessable
R7.htm Edgar Link pending
R7.xml Edgar Link unprocessable
R8.htm Edgar Link pending
R8.xml Edgar Link unprocessable
R9.htm Edgar Link pending
R9.xml Edgar Link unprocessable
report.css Edgar Link pending
Show.js Edgar Link pending